Mei Tang

At Daiichi Sankyo, my role as senior medical director centers on pioneering innovative cancer therapeutics, with a current focus on B7-H3 directed ADC and DLL3 TCE. I am very collaborative with intensive experiences in leading cross-functional teams, designing clinical trials, medical monitoring, and interacting with investigators and health authorities. Through my training in medical school and clinical practice, I learned firsthand the power of science to change lives. During my 19-year career in industry, I led a global team, executed multiple trials successfully under rigorous development timelines and secured multiple regulatory approval.